GrayOS, developed by Gray Oncology Solutions, is being implemented at CancerCare Manitoba (CCMB) to enhance access to systemic therapy and improve efficiency in cancer care delivery. CCMB is pleased to partner with Gray in bringing this innovative platform to Manitoba.
Health Technology Insights: Purdue Pharma Plan of Reorganization Receives Overwhelming Creditor Support
Like many cancer programs across North America, CCMB is working to maintain timely access to care amid rising patient volumes and increasingly complex treatment pathways. As cancer incidence grows and therapies become more personalized, coordinating systemic therapy schedules has become a demanding operational challenge.
Scheduling systemic therapy involves managing multiple interrelated factors — including drug preparation, lab test results, resource availability, and individualized treatment protocols. These variables make it difficult to balance capacity with patient needs. Inefficient scheduling can result in lost treatment capacity, as much as 15% in some centres — leading to longer wait times for patients and uneven workloads for staff.
Health Technology Insights: Genesys Cloud AI Enhances Patient Care at Steinberg Diagnostic Medical Imaging
With GrayOS, CCMB teams can better align capacity with demand through advanced optimization algorithms and scheduling automation. The solution helps forecast cancellations, automatically adjusts schedules to last-minute changes, and integrates directly with ARIA through its API. This ensures seamless coordination across clinical and administrative teams, without the need for double entry between ARIA and GrayOS.
By using GrayOS, CCMB aims to make systemic therapy operations more efficient, reduce patient wait times, and improve the daily experience for both patients and staff.
CCMB is also partnering with Gray to develop new AI-powered features designed to further enhance access to care and strengthen the resilience of systemic therapy operations. This initiative is part of a broader innovation project supported by Scale AI, with additional details to be announced soon.
“We’re proud to partner with CancerCare Manitoba to support their mission of timely, high-quality care,” said André Diamant, CEO of Gray Oncology Solutions. “Behind every scheduling decision is a patient waiting for treatment. Our collaboration is about giving care teams the tools to reduce delays and deliver care when it matters most.”
“At CancerCare Manitoba, every innovation we pursue is grounded in improving patient outcomes, enhancing the patient experience, and empowering our teams,” said Ken N. Borce, Vice President of Clinical Operations and Chief Nursing Officer at CancerCare Manitoba. “Integrating GrayOS into our systemic therapy workflows enables us to coordinate complex treatments with greater efficiency and flexibility. This technology allows our healthcare professionals to focus on what matters most, delivering the best possible care to Manitobans affected by cancer and blood disorders.”
Health Technology Insights: Praia Health Launches AI Tool Boosting Patient Conversions
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
